Unknown

Dataset Information

0

Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells.


ABSTRACT: The CRISPR/Cas9 system has been used for spatio-temporal gene modification through the ubiquitous expression of gRNA by an RNA polymerase III promoter and the controlled expression of Cas9 using a tissue-specific or inducible promoter. However, unexpected gene disruptions indicate the necessity of a tissue-specific or inducible expression of not only Cas9 but also gRNA. In the present study, we attempted to develop a CRISPR/Cas9 system that could express functional gRNAs and Cas9 by a single RNA polymerase II promoter and induce multi-loci disruptions in specific cells. To this end, we designed vectors expressing ribozyme-flanked gRNAs (RGRs) and Cas9 mRNAs simultaneously. We showed that the mono-promoter-driven vector induces gene disruptions at the target loci in HEK 293 cells after transfection. In addition, two target loci were disrupted simultaneously by the transfection of a mono-promoter-driven vector expressing two RGRs and Cas9 mRNA. Finally, we constructed a universal vector for use in the construction of plasmids to be applied to the present mono-promoter-driven CRISPR/Cas9 system. We have thus provided a versatile tool for generating gene disruptions by the CRISPR/Cas9 system; this system should contribute to a wide range of investigations, including studies on spatio-temporal gene functions.

SUBMITTER: Yoshioka S 

PROVIDER: S-EPMC4680873 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells.

Yoshioka Shin S   Fujii Wataru W   Ogawa Tetsuhiro T   Sugiura Koji K   Naito Kunihiko K  

Scientific reports 20151216


The CRISPR/Cas9 system has been used for spatio-temporal gene modification through the ubiquitous expression of gRNA by an RNA polymerase III promoter and the controlled expression of Cas9 using a tissue-specific or inducible promoter. However, unexpected gene disruptions indicate the necessity of a tissue-specific or inducible expression of not only Cas9 but also gRNA. In the present study, we attempted to develop a CRISPR/Cas9 system that could express functional gRNAs and Cas9 by a single RNA  ...[more]

Similar Datasets

| S-EPMC4786937 | biostudies-literature
| S-EPMC6108506 | biostudies-literature
| S-EPMC4145672 | biostudies-literature
| S-EPMC8844242 | biostudies-literature
| S-EPMC6880386 | biostudies-literature
| S-EPMC6181213 | biostudies-literature
| S-EPMC6899835 | biostudies-literature
| S-EPMC3972032 | biostudies-literature
| S-EPMC4413877 | biostudies-literature
| S-EPMC9226529 | biostudies-literature